|
🐜
|
Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis
40 auth.
J. W. Brown,
A. Coles,
D. Horáková,
E. Havrdová,
G. Izquierdo,
A. Prat,
M. Girard,
P. Duquette,
M. Trojano,
A. Lugaresi,
R. Bergamaschi,
P. Grammond,
R. Alroughani,
R. Hupperts,
P. Mccombe,
...
V. van Pesch,
P. Sola,
D. Ferraro,
F. Grand'Maison,
M. Terzi,
J. Lechner-Scott,
S. Flechter,
M. Slee,
V. Shaygannejad,
E. Pucci,
F. Granella,
V. Jokubaitis,
M. Willis,
C. Rice,
N. Scolding,
A. Wilkins,
O. Pearson,
T. Ziemssen,
M. Hutchinson,
K. Harding,
Joanne L. Jones,
C. McGuigan,
H. Butzkueven,
T. Kalincik,
N. Robertson
|
8 |
2019 |
8
🐜
|
|
🐜
|
Sex as a determinant of relapse incidence and progressive course of multiple sclerosis.
49 auth.
T. Kalincik,
V. Vivek,
V. Jokubaitis,
J. Lechner-Scott,
M. Trojano,
G. Izquierdo,
A. Lugaresi,
F. Grand'Maison,
R. Hupperts,
C. Oreja-Guevara,
R. Bergamaschi,
G. Iuliano,
R. Alroughani,
V. van Pesch,
M. Amato,
...
M. Slee,
F. Verheul,
R. Fernández‐Bolaños,
M. Fiol,
D. Spitaleri,
E. Cristiano,
O. Gray,
J. Cabrera-Gomez,
V. Shaygannejad,
J. Herbert,
S. Vucic,
M. Needham,
T. Petkovska-Boskova,
C. Sîrbu,
P. Duquette,
M. Girard,
P. Grammond,
C. Boz,
G. Giuliani,
M. Rio,
M. Barnett,
S. Flechter,
F. Moore,
B. Singhal,
E. Bacile,
M. Saladino,
C. Shaw,
E. Skromne,
D. Poehlau,
N. Vella,
T. Spelman,
D. Liew,
T. Kilpatrick,
H. Butzkueven
|
7 |
2013 |
7
🐜
|
|
🐬
|
Comparison of the efficacy of azathioprine and rituximab in neuromyelitis optica spectrum disorder: a randomized clinical trial
Zahra Nikoo,
Shervin Badihian,
V. Shaygannejad,
N. Asgari,
F. Ashtari
|
7 |
2017 |
7
🐬
|
|
🐬
|
Prevalence of Multiple Sclerosis in Isfahan, Iran
M. Etemadifar,
M. Janghorbani,
V. Shaygannejad,
F. Ashtari
|
7 |
2006 |
7
🐬
|
|
🐜
|
Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS
36 auth.
K. Ribbons,
P. McElduff,
C. Boz,
M. Trojano,
G. Izquierdo,
P. Duquette,
M. Girard,
F. Grand'Maison,
R. Hupperts,
P. Grammond,
C. Oreja-Guevara,
T. Petersen,
R. Bergamaschi,
G. Giuliani,
M. Barnett,
...
V. van Pesch,
M. Amato,
G. Iuliano,
M. Fiol,
M. Slee,
F. Verheul,
E. Cristiano,
R. Fernández‐Bolaños,
M. Saladino,
M. Rio,
J. Cabrera-Gomez,
H. Butzkueven,
E. V. van Munster,
Leontien den Braber-Moerland,
Daniele La Spitaleri,
A. Lugaresi,
V. Shaygannejad,
O. Gray,
N. Deri,
R. Alroughani,
J. Lechner-Scott
|
7 |
2015 |
7
🐜
|
|
🦁
|
In response
V. Shaygannejad
|
7 |
2009 |
7
🦁
|
|
🐜
|
Persistence on Therapy and Propensity Matched Outcome Comparison of Two Subcutaneous Interferon Beta 1a Dosages for Multiple Sclerosis
85 auth.
T. Kalincik,
T. Spelman,
M. Trojano,
P. Duquette,
G. Izquierdo,
P. Grammond,
A. Lugaresi,
R. Hupperts,
E. Cristiano,
V. van Pesch,
F. Grand'Maison,
Daniele La Spitaleri,
M. Rio,
S. Flechter,
C. Oreja-Guevara,
...
G. Giuliani,
A. Savino,
M. Amato,
T. Petersen,
R. Fernández‐Bolaños,
R. Bergamaschi,
G. Iuliano,
C. Boz,
J. Lechner-Scott,
N. Deri,
O. Gray,
F. Verheul,
M. Fiol,
M. Barnett,
E. V. van Munster,
Vetere Santiago,
F. Moore,
M. Slee,
M. Saladino,
R. Alroughani,
C. Shaw,
Krisztián Kása,
T. Petkovska-Boskova,
Leontien den Braber-Moerland,
J. Chapman,
E. Skromne,
J. Herbert,
D. Poehlau,
M. Needham,
E. B. Bacile,
W. Arruda,
M. Paine,
B. Singhal,
S. Vucic,
J. Cabrera-Gomez,
H. Butzkueven,
Élaine Roger,
P. Despault,
M. Marriott,
A. van der Walt,
J. King,
T. Kilpatrick,
K. Buzzard,
V. Jokubaitis,
J. Byron,
Lisa T. Morgan,
O. Skibina,
J. Haartsen,
G. De Luca,
V. Di Tommaso,
D. Travaglini,
E. Pietrolongo,
M. di Ioia,
D. Farina,
L. Mancinelli,
D. Paolicelli,
P. Iaffaldano,
Juan Ignacio Rojas,
L. Patrucco,
E. Roullet,
J. Correale,
Célica Ysrraelit,
Cartechini Elisabetta,
E. Pucci,
David B. Williams,
L. Dark,
V. Shaygannejad,
C. Zwanikken,
N. Vella,
C. Sîrbu
|
7 |
2013 |
7
🐜
|
|
🐜
|
Towards personalized therapy for multiple sclerosis: prediction of individual treatment response
47 auth.
T. Kalincik,
A. Manouchehrinia,
L. Sobíšek,
V. Jokubaitis,
T. Spelman,
D. Horáková,
E. Havrdová,
M. Trojano,
G. Izquierdo,
A. Lugaresi,
M. Girard,
A. Prat,
P. Duquette,
P. Grammond,
P. Sola,
...
R. Hupperts,
F. Grand'Maison,
E. Pucci,
C. Boz,
R. Alroughani,
V. van Pesch,
J. Lechner-Scott,
M. Terzi,
R. Bergamaschi,
G. Iuliano,
F. Granella,
D. Spitaleri,
V. Shaygannejad,
C. Oreja-Guevara,
M. Slee,
R. Ampapa,
F. Verheul,
P. Mccombe,
J. Olascoaga,
M. Amato,
S. Vucic,
S. Hodgkinson,
C. Ramo-Tello,
S. Flechter,
E. Cristiano,
C. Rozsa,
F. Moore,
J. Sánchez-Menoyo,
M. Saladino,
M. Barnett,
J. Hillert,
H. Butzkueven
|
6 |
2017 |
6
🐜
|
|
🦁
|
Comparison of the Effect of Topiramate and Sodium Valporate in Migraine Prevention: A Randomized Blinded Crossover Study
V. Shaygannejad,
M. Janghorbani,
A. Ghorbani,
F. Ashtary,
Naser Zakizade,
Vida Nasr
|
6 |
2006 |
6
🦁
|
|
🐬
|
Biased Treg/Th17 balance away from regulatory toward inflammatory phenotype in relapsed multiple sclerosis and its correlation with severity of symptoms
A. Jamshidian,
V. Shaygannejad,
A. Pourazar,
S. Zarkesh-Esfahani,
M. Gharagozloo
|
6 |
2013 |
6
🐬
|
